Experience

Desbiens Consulting, LLC Product Management / Strategy

Independent Biopharmaceutical Consultant

10/2022 - Present

Provide strategic and business consulting services to biotechnology and pharmaceutical companies.

---

Alnylam Pharmaceuticals Marketing

Director, New Product Commercialization, Global Marketing and Commercial Strategy

4/2019 - 4/2022

Global commercial lead for zilebesiran (ALN-AGT), Alnylam's first fully owned program in a highly prevalent disease. Collaborated with Program and Research Teams to establish the unmet need, opportunity, need-to-believe criteria, and strategy for zilebesiran in cardiovascular diseases and other early stage clinical and pre-clinical assets for rare diseases.

---

Genentech Data Science / Analytics

Group Lead, SI&A Oncology, Global Product Strategy

3/2018 - 3/2019

Led a team of six providing customer insights and commercial assessments for pipeline and marketed products in oncology. Oversaw the development of insights for Tecentriq pan-tumor activities and business reviews.

---

Genentech Marketing

International Product Manager for Tecentriq (50% rotation)

9/2017 - 3/2018

Identified critical pre-launch challenges and opportunities for Tecentriq in early triple-negative breast cancer (eTNBC). Drove alignment within the International Business Team (IBT) on key strategies to optimize launch and communicate guidance to the affiliates. Led the development and roll-out of the Tecentriq eTNBC Integrated Strategy (across commercial, medical, and access) and the Global Commercial Plan.

---

Genentech Data Science / Analytics

Senior Strategic Insights Manager, SI&A Oncology, Global Product Strategy

1/2016 - 1/2018

Supported multidisciplinary oncology teams in maximizing the value of early stage assets (pre and post-IND) and in evaluating BD opportunities by communicating key commercial and clinical drivers through market research insights, analogs, and revenue forecasts.

---

Genentech Marketing

Ad Interim Disease Area Director, Breast Cancer, Global Product Strategy

4/2017 - 8/2017

Provided commercial strategic direction to gRED molecule teams and led the activities of the associated commercial subteams, leading to the submission and approval of three IND applications. Co-led the development, endorsement and roll-out of the Global HR+ Breast Cancer Disease Area Strategy.

---

Self-employed Product Management / Strategy

Independent consultant

9/2015 - 12/2015

Created epidemiology and revenue forecasts for three assets across five indications, including pediatric orphan diseases, to support a small biotech in a reverse merger.

---

Massachusetts Institute of Technology Other

Assistant Director for Adaptive Licensing, NEWDIGS Initiative, Center for Biomedical Innovation

5/2014 - 1/2015

Led planning and implementation of a new program to evaluate and improve global data readiness to support adaptive licensing and other accelerated access paradigms. Managed a senior-level virtual, multi-stakeholder working group including pharmaceutical manufacturers, regulators, payers, HTAs, and patient advocacy groups.

---

Decision Resources Group Product Management / Strategy

Principal Consultant

1/2010 - 4/2014

Promoted every year from Associate Consultant (entry level) to Principal. Successfully planned, managed, and executed strategic consulting engagements for pharmaceutical companies, including opportunity assessments, product positioning, growth and lifecycle strategy, and BD&L support.